Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · prior close shown (market closed)
Investment Snapshot
Why it matters
GLOBUS MEDICAL INC shows decelerating business momentum based on AlphaOS pipeline evidence.
Why it matters: Revenue +6% YoY in Q2 FY2026.
3 signals not yet derived from pipeline evidence
Key signals
What it means for the thesis — synthesis, not a raw event feed.
- Revenue +6% YoY in Q2 FY2026
Pipeline evidence · 22d ago
GMED's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on GMED.
Free accounts see more of this; Premium sees all of it.
Latest earnings · Q2 2026
Full GMED earnings analysisReported figures for GLOBUS MEDICAL INC — research only, not investment advice.
- Revenue YoY
- +5.9%
- EPS YoY
- -26.2%
Latest Intelligence
Updated
What happened recently for GLOBUS MEDICAL INC (GMED) — events, not interpretation.
- Event
- Reported Q2 2026 revenue +6% YoY.
- Also
- Last session September 28, 2026 at $74.78.
- Source
- Q2 2026 earnings
Research & analysis only — not investment advice.
Industry & ETF context
Industry blend 52- Primary industry Medical Instruments & Supplies scores 52/100 (Recovery cycle, Weak momentum).
- Held in 2 ETF(s) — largest weight IHI (1.43%).
AlphaOS industries
Investment snapshot
GLOBUS MEDICAL INC
GMED's AI investment thesis
Upgrade to Premium for GMED's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Intelligence layer
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
- →Filing signal: Officer/director transaction language detected
- →Held in 2 ETF(s) — largest weight IHI (1.43%).
Strengthen intelligence
- · Run earnings AI analysis on latest quarter
- · Fetch earnings call transcript for CEO commentary
Prior close
$74.78
Market cap
$10.04B
Profitable
Yes
Revenue $2.94B
Net income
$537.87M
FY Dec 31, 2025
Analyst ratings
Loading Wall Street consensus…
Earnings intelligence
Full earnings centerLoading earnings intelligence…
Technical intelligence
Building technical intelligence snapshot — check back shortly.
Loading market context…
Price & volume
0 trading daysNo price history. Sync market data to load charts.
Filing insights
Loading SEC filing intelligence…
Competitive landscape
Recent SEC filings
Filings tabNo filings ingested yet.
GLOBUS MEDICAL INC (GMED)
Investment Snapshot above is the primary AlphaOS analysis for GLOBUS MEDICAL INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Key facts
- Sector:
- Healthcare
- Industry:
- Medical Instruments & Supplies
- Market cap:
- $10.04B
- Revenue:
- $2.94B
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected intelligence
Follow GLOBUS MEDICAL INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Related & Connected
Related stock research
Connected companies and research pages from the AlphaOS knowledge graph.
- HUMANA INC (HUM)Investment Snapshot & knowledge graph →
- CANADIAN PACIFIC KANSAS CITY LTD/CN (CP)Investment Snapshot & knowledge graph →
- CAMECO CORP (CCJ)Investment Snapshot & knowledge graph →
- UNION PACIFIC CORP (UNP)Investment Snapshot & knowledge graph →
- CARDINAL HEALTH INC (CAH)Investment Snapshot & knowledge graph →
- PACCAR INC (PCAR)Investment Snapshot & knowledge graph →
Related stock research
Structured stock intelligence for companies connected to this research.